These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12888137)

  • 21. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive lowering of low-density lipoprotein cholesterol: do the studies apply to the elderly?
    DeSilvey DL
    Am J Geriatr Cardiol; 2004; 13(4):217-8. PubMed ID: 15269569
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina.
    Zhao Z; Geng J; Ge ZM; Wang W; Zhang Y; Kang WQ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):554-8. PubMed ID: 19673939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Statins and unstable angina: MIRACL].
    Puel J
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):145-8. PubMed ID: 11240417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
    Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
    J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of atorvastatin on exercise-induced myocardial ischemia in patients with stable angina pectoris.
    Bogaty P; Dagenais GR; Poirier P; Boyer L; Auclair L; Pépin G; Jobin J; Arsenault M
    Am J Cardiol; 2003 Nov; 92(10):1192-5. PubMed ID: 14609594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
    Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol.
    Kanadaşi M; Cayli M; Demirtaş M; Inal T; Demir M; Koç M; Avkaroğullari M; Dönmez Y; Usal A; Alhan CC; San M
    Heart Vessels; 2006 Sep; 21(5):291-7. PubMed ID: 17151816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.
    Cannon CP; McCabe CH; Belder R; Breen J; Braunwald E
    Am J Cardiol; 2002 Apr; 89(7):860-1. PubMed ID: 11909576
    [No Abstract]   [Full Text] [Related]  

  • 30. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease.
    Pérez-Castrillón JL; Vega G; Abad L; Sanz A; Chaves J; Hernandez G; Dueñas A
    Am J Cardiol; 2007 Apr; 99(7):903-5. PubMed ID: 17398180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury.
    Yu XL; Zhang HJ; Ren SD; Geng J; Wu TT; Chen WQ; Ji XP; Zhong L; Ge ZM
    Coron Artery Dis; 2011 Mar; 22(1):87-91. PubMed ID: 21169815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
    Schwartz GG; Bessac L; Berdan LG; Bhatt DL; Bittner V; Diaz R; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Mahaffey KW; Moryusef A; Pordy R; Roe MT; Rorick T; Sasiela WJ; Shirodaria C; Szarek M; Tamby JF; Tricoci P; White H; Zeiher A; Steg PG
    Am Heart J; 2014 Nov; 168(5):682-9. PubMed ID: 25440796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
    Arsenault BJ; Barter P; DeMicco DA; Bao W; Preston GM; LaRosa JC; Grundy SM; Deedwania P; Greten H; Wenger NK; Shepherd J; Waters DD; Kastelein JJ;
    J Am Coll Cardiol; 2011 Jan; 57(1):63-9. PubMed ID: 21185503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein levels and outcomes after statin therapy.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):8-9. PubMed ID: 16455006
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial.
    O'Donoghue M; Morrow DA; Sabatine MS; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    Circulation; 2006 Apr; 113(14):1745-52. PubMed ID: 16537575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
    N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
    Mega JL; Morrow DA; Cannon CP; Murphy S; Cairns R; Ridker PM; Braunwald E
    J Thromb Thrombolysis; 2006 Aug; 22(1):71-6. PubMed ID: 16786236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
    Tousoulis D; Bosinakou E; Kotsopoulou M; Antoniades C; Katsi V; Stefanadis C
    Int J Cardiol; 2006 Jan; 106(3):333-7. PubMed ID: 16337041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.